Letter: tricky reactions to switch back from subcutaneous to intravenous vedolizumab in patients with inflammatory bowel disease

LINKED CONTENT This article is linked to Volkers et al papers. To view these articles, visit https://doi.org/10.1111/apt.17153 and https://doi.org/10.1111/apt.17407

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Alimentary Pharmacology & Therapeutics (Suppl) 2023-03, Vol.57 (6), p.741-742
Hauptverfasser:	Richard, Nicolas, Vuitton, Lucine, Fumery, Mathurin
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Intravenous Antibodies, Monoclonal, Humanized - therapeutic use Colitis, Ulcerative - drug therapy Gastrointestinal Agents - therapeutic use Human health and pathology Humans Inflammatory bowel diseases Inflammatory Bowel Diseases - drug therapy Life Sciences Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	LINKED CONTENT This article is linked to Volkers et al papers. To view these articles, visit https://doi.org/10.1111/apt.17153 and https://doi.org/10.1111/apt.17407
ISSN:	0269-2813 0953-0673 1365-2036
DOI:	10.1111/apt.17395